Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1976 1
1978 3
1982 1
1983 3
1984 3
1985 6
1986 6
1987 3
1989 1
1990 1
1991 2
1992 4
1993 2
1994 1
1995 1
1996 2
1997 4
1998 12
1999 6
2000 9
2001 10
2002 7
2003 9
2004 7
2005 10
2006 12
2007 13
2008 13
2009 11
2010 11
2011 11
2012 3
2013 7
2014 4
2015 4
2016 4
2017 7
2018 4
2019 8
2020 4
2021 5
2022 7
2023 2
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT.
Nakagawa N, Ishiyama K, Usuki K, Takada S, Tomikawa T, Handa H, Katsuoka Y, Hirano D, Sezaki N, Sumi M, Fujisawa S, Taniguchi Y, Mugitani A, Yoshimura T, Ohtsuka E, Takase K, Suehiro Y, Ota S, Kajiguchi T, Maeda T, Yamamoto M, Ohtake S, Katsumi A, Kiyoi H, Matsumura I, Miyazaki Y. Nakagawa N, et al. Among authors: katsuoka y. Ann Hematol. 2024 Jan;103(1):307-320. doi: 10.1007/s00277-023-05527-5. Epub 2023 Nov 8. Ann Hematol. 2024. PMID: 37940714
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia.
Usuki K, Miyamoto T, Yamauchi T, Ando K, Ogawa Y, Onozawa M, Yamauchi T, Kiyoi H, Yokota A, Ikezoe T, Katsuoka Y, Takada S, Aotsuka N, Morita Y, Ishikawa T, Asada N, Ota S, Dohi A, Morimoto K, Imai S, Kishimoto U, Akashi K, Miyazaki Y; Study Group for NS-87/CPX-351. Usuki K, et al. Among authors: katsuoka y. Int J Hematol. 2024 Jun;119(6):647-659. doi: 10.1007/s12185-024-03733-z. Epub 2024 Mar 26. Int J Hematol. 2024. PMID: 38532078 Free PMC article. Clinical Trial.
Metastases to the penis from carcinoma of the prostate.
Kotake Y, Gohji K, Suzuki T, Watsuji T, Kusaka M, Takahara K, Ubai T, Noumi H, Inamoto T, Shibahara N, Ueda H, Katsuoka Y. Kotake Y, et al. Among authors: katsuoka y. Int J Urol. 2001 Feb;8(2):83-6. doi: 10.1046/j.1442-2042.2001.00245.x. Int J Urol. 2001. PMID: 11240832 Free article. Review.
[Human heparanase: roles in invasion and metastasis of cancer].
Gohji K, Katsuoka Y, Okamoto M, Kamidono S, Kitazawa S, Toyoshima M, Dong J, Nakajima M. Gohji K, et al. Among authors: katsuoka y. Hinyokika Kiyo. 2000 Oct;46(10):757-62. Hinyokika Kiyo. 2000. PMID: 11215206 Free article. Review. Japanese.
Comparison of fludarabine-based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry-based study.
Kurita N, Imahashi N, Chiba S, Tanaka M, Kobayashi H, Uchida N, Kuriyama T, Anzai N, Nawa Y, Nakano N, Ara T, Onizuka M, Katsuoka Y, Koi S, Kimura T, Ichinohe T, Atsuta Y, Kanda J; Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Kurita N, et al. Among authors: katsuoka y. Am J Hematol. 2024 Feb;99(2):236-244. doi: 10.1002/ajh.27172. Epub 2024 Jan 2. Am J Hematol. 2024. PMID: 38165068
Gemicitabine resistence and mesenchymal phenotype.
Inamoto T, Azuma H, Katsuoka Y. Inamoto T, et al. Among authors: katsuoka y. Ann Surg Oncol. 2009 May;16(5):1435-6. doi: 10.1245/s10434-008-0309-0. Epub 2009 Jan 29. Ann Surg Oncol. 2009. PMID: 19184229 No abstract available.
236 results